(Q30428471)

21 June 2017

1 reference

title

Myelodysplasia and the leukemias (English)

1 reference

21 June 2017

Jacobs P

1

1 reference

21 June 2017

publication date

1 August 1997

1 reference

21 June 2017

1 reference

21 June 2017

volume

43

1 reference

21 June 2017

issue

8

1 reference

21 June 2017

page(s)

505-597

1 reference

Histology of normal haemopoiesis: bone marrow histology. I

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Conditions controlling the proliferation of haemopoietic stem cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

The hematopoietic microenvironment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Characteristics of the hematopoietic stem cell compartment in adult mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Stochastic effects in hemopoiesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Stromal cells from the bone marrow: evidence for a restrictive role in regulation of hemopoiesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Hematopoietic lineage commitment: role of transcription factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

The clinical application of molecular techniques in Philadelphia-positive leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

The cyclin-dependent protein kinases and the control of cell division.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Adhesion molecules--Part 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Adhesion molecules--Part II: Blood vessels and blood cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Human haemopoietic stem cell assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Acquired Aplasia of the Bone Marrow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Myelodysplastic syndromes in childhood: report of 49 patients from a French multicentre study. French Society of Paediatric Haematology and Immunology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Proposals for the classification of the myelodysplastic syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Morphologic classification of the myelodysplastic syndromes (MDS): Combined utilization of bone marrow aspirates and trephine biopsies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Chromosomal deletions in the myelodysplastic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Use of granulocyte colony-stimulating factor before, during, and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: comparison with fludarabine plus cytarabine without gran

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Diagnostic criteria for hypocellular acute leukemia: a clinical entity distinct from overt acute leukemia and myelodysplastic syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Immunologic indices in myelodysplastic syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Myelodysplastic syndromes: a scoring system with prognostic significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Prognostic factors in myelodysplastic syndromes: analysis of five scoring systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Cytohematologic and cytogenetic prognostic factors at diagnosis and in the evolution in 46 primary myelodysplastic syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Myelodysplastic syndromes in the elderly: the role of growth factors in management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Combined differentiating therapy for myelodysplastic syndromes: a phase II study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Intensive chemotherapy in myelodysplastic syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

A study of the natural history of acute leukemia with special reference to the duration of the disease and the occurrence of remissions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Epidemiology of acute leukaemia in the Cape Province of South Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French-American-British Cooperative Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Clonal chromosomal abnormalities showing multiple-cell-lineage involvement in acute myeloid leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Molecular diagnosis and monitoring of acute myeloid leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Optimising Treatment for Elderly Patients with Acute Leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Biological characteristics of newly diagnosed poor prognosis acute myelogenous leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Chromosome aberrations in CD34-positive acute myeloid leukemia. Correlation with clinicopathologic features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

The clinical value of detecting gene rearrangements in acute leukaemias.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Long term survival in acute myeloid leukemia: the Eastern Cooperative Oncology Group (ECOG) experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Assessment of values, utilities and preferences in cancer patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Monotherapy for fever and neutropenia in cancer patients: a randomized comparison of ceftazidime versus imipenem

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Antineoplastic drugs in 1990. A review (Part II).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Comparative pharmacokinetic study of idarubicin and daunorubicin in leukemia patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

The role of mitozantrone in the treatment of acute leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Intensified Induction and Post-Remission Therapy for Acute Myeloid Leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Ad

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. Pediatric Oncology Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

7 January 2021

Lifestyle and leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Beta-1-integrin expression in adult acute lymphoblastic leukemia: possible relationship with the stem cell antigen CD34.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Cytomorphology of childhood lymphoblastic leukaemia: a prospective study of 2000 patients. United Kingdom Medical Research Council's Working Party on Childhood Leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Unusual immunophenotypes in acute leukaemias: incidence and clinical correlations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Significance of aberrant immunophenotypes in childhood acute lymphoid leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Incidence and treatment of tumor lysis syndrome in patients with acute leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Acute leukemia in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

The use of glucocorticoids in acute lymphoblastic leukemia of childhood. Molecular, cellular, and clinical considerations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Karnofsky memorial lecture. Ode to methotrexate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Mercaptopurine metabolism and risk of relapse in childhood lymphoblastic leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Silence of the leukemic clone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Treatment of overt isolated testicular relapse in children on therapy for acute lymphoblastic leukemia. A report from the Childrens Cancer Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Prevention of CNS disease in intermediate-risk acute lymphoblastic leukemia: comparison of cranial radiation and intrathecal methotrexate and the importance of systemic therapy: a Childrens Cancer Group report.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Risk factors for intellectual and educational sequelae of cranial irradiation in childhood acute lymphoblastic leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Results of Medical Research Council trial UKALL IX in acute lymphoblastic leukaemia in adults: report from the Medical Research Council Working Party on Adult Leukaemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

An assessment of the clinicohematological criteria for the accelerated phase of chronic myeloid leukemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Chronic myelogenous leukemia: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Comparison of bcr-abl protein expression and Philadelphia chromosome analyses in chronic myelogenous leukemia patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Chronic myelogenous leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals by the French-American-British Cooperative Leukaemia Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Comparison of bone marrow histology in early chronic granulocytic leukemia and in leukemoid reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Chromosomal characteristics of chronic and blastic phase of chronic myeloid leukemia. A study of 100 patients in India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Chronic myeloid leukemia as an immunological target

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Prognostic features at diagnosis of chronic myelocytic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Long-term survivors in chronic granulocytic leukaemia: a study by the International CGL Prognosis Study Group. Italian Cooperative CML Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Hydroxyurea treatment for chronic myeloid leukaemia during pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Complete hematologic remissions in chronic-phase, Philadelphia-chromosome-positive, chronic myelogenous leukemia after 2-chlorodeoxyadenosine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Options for therapy in chronic myeloid leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Interferon-alpha therapy for chronic myelogenous leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Adoptive immunotherapy for relapsed leukemia following allogeneic bone marrow transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Autotransplants in chronic myelogenous leukaemia: strategies and results.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Chronic lymphoid leukemias: recent advances in biology and therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Type C hepatitis and chronic lymphocytic leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Trisomy 12 in chronic lymphocytic leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Richter's syndrome in a case of atypical chronic lymphocytic leukaemia with the t(11;14)(q13;q32): role for a p53 exon 7 gene mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Immunophenotyping of low-grade B-cell lymphoma in blood and bone marrow: poor correlation between immunophenotype and cytological/histological classification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Multiple myeloma and chronic lymphocytic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Regulation and function of adhesion molecules in B-cell chronic lymphocytic leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Prognostic significance of immune function parameters in patients with chronic lymphocytic leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Prognostic factors in chronic lymphocytic leukaemia: the importance of age, sex and response to treatment in survival. A report from the MRC CLL 1 trial. MRC Working Party on Leukaemia in Adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Chronic lymphocytic leukaemia treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia. The French Cooperative Group on CLL

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Chronic lymphocytic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Humanized CD52 monoclonal antibody campath-1H as first-line treatment in chronic lymphocytic leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Splenectomy in advanced chronic lymphocytic leukemia: a single institution experience with 50 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia. European Group for Blood and Marrow Transplantation and the International Bone Marrow Transplant Registry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia: preliminary results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. II. Patterns of evolution of 'prolymphocytoid' transformation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

The role of pentostatin in the treatment of T-cell malignancies: analysis of response rate in 145 patients according to disease subtype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Human T-cell leukemia virus (HTLV-I) antibodies in Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

Deregulation of cell cycle control in hematologic malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-5029%2897%2990027-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0011-5029(97)90027-4

1 reference

21 June 2017

1 reference